Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S0220: Induction Chemoradiotherapy + Surgery + Docetaxel for Pancoast Tumors
NCT00062439Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Jul 2003
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel in non-small cell lung cancer (NSCLC), sponsored by SWOG Cancer Research Network. Primary endpoint: Feasibility of Administering Induction Chemoradiotherapy Followed by Surgical Resection and Adjuvant Docetaxel. Started Jul 2003; status: completed.
02
Drugs
docetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00062439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00062439.